INOVIO PHARMACEUTICALS, INC. Proceeds from Sale of Productive Assets
INOVIO PHARMACEUTICALS, INC. (INO) reported Proceeds from Sale of Productive Assets of $650.00 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfProductiveAssets · last filed 2012-11-07
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of productive assets for the quarter ending 2012-09-30 was $500.00K, a 400.00% increase year-over-year.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of productive assets for the quarter ending 2012-06-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of productive assets for the quarter ending 2012-03-31 was $150.00K, a 40.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of productive assets for the quarter ending 2011-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. proceeds from sale of productive assets for fiscal 2011 was $350.00K.
| Period end | Proceeds from Sale of Productive Assets 3 month | Proceeds from Sale of Productive Assets 6 month | Proceeds from Sale of Productive Assets 9 month | Proceeds from Sale of Productive Assets 12 month |
|---|---|---|---|---|
| 2012-09-30 | $500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $500.00K derived: sum of 2 quarters · filed 2012-11-07 | $650.00K 10-Q · filed 2012-11-07 | $650.00K derived: sum of 4 quarters · filed 2012-11-07 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $150.00K 10-Q · filed 2012-08-09 | $150.00K derived: sum of 3 quarters · filed 2012-08-09 | $250.00K derived: sum of 4 quarters · filed 2012-11-07 |
| 2012-03-31 | $150.00K 10-Q · filed 2012-05-09 | $150.00K derived: sum of 2 quarters · filed 2012-05-09 | $250.00K derived: sum of 3 quarters · filed 2012-11-07 | $250.00K derived: sum of 4 quarters · filed 2012-11-07 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $100.00K derived: sum of 2 quarters · filed 2012-11-07 | $100.00K derived: sum of 3 quarters · filed 2012-11-07 | $350.00K 10-K · filed 2012-03-15 |
| 2011-09-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $100.00K derived: sum of 2 quarters · filed 2012-11-07 | $350.00K 10-Q · filed 2012-11-07 | |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $250.00K 10-Q · filed 2012-08-09 | ||
| 2011-03-31 | $250.00K 10-Q · filed 2012-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |